Media Center

• At #AGS23, @AmerGeriatrics and #geriatrics experts cast a wide net for social & scientific innovations shaping better care for us all as we age. http://ow.ly/gLWj50Nt1lI

New York (March 27, 2023) – Researchers presenting at this year’s American Geriatrics Society (AGS) Annual Scientific Meeting (#AGS23) to be held May 4-6, 2023 in Long Beach, California, represent the best and brightest in geriatrics scholarship, with this year’s selection drawn from a pool of more than 1071 submissions. Highlights from this year’s prestigious AGS23 Plenary Paper Session (Thurs., May 4 9:30-10:15am) include:

When Should Electronic Medical Records Stop Reminders for Cancer Screening in Older Adults? – A National Physician Survey (presented by Nancy L. Schoenborn, MD, MHS)

• Today, the AGS (@amergeriatrics) announced the results of recent AGS Board and Nominating Committee elections. See here for details: http://ow.ly/iuxL50NeIO

New York (March 10, 2023) – Today, the American Geriatrics Society (AGS) announced the results of recent AGS Board and Nominating Committee elections.

The AGS Board and Nominating Committee are comprised of geriatrics health professionals who are committed to improving the health, independence, and quality of life for all of us as we age. The following AGS Members were elected to the AGS Board of Directors by AGS members:

Mark Supiano, MD, AGSF, AGS President-Elect

Mark Supiano, MD, AGSF is the Chief of the Geriatrics Division at the University of Utah, where he also serves as the Executive Director of the university’s Center on Aging. An AGS member since 1985, Dr. Supiano has held many leadership roles within the Society, including: Program Chair of the 2006 AGS Annual Scientific Meeting, Associate Editor of the JAGS Editorial Board (2000-2005), and as a Board Member of the ADGAP Board of Directors (2007-2017), ultimately serving as both its President and Board Chair. Dr. Supiano is now concluding his third year as AGS Treasurer.   

Judith L. Beizer, PharmD, BCGP, FASCP, AGSF, AGS Board Member (2nd term)

• AGS supports CMS’ decision to not reopen its NCD on monoclonal antibodies and appreciates CMS’ commitment to review any new evidence that becomes available, such as evidence of clinical benefit, that may lead CMS to reconsider the NCD. http://ow.ly/nExW50N6pS

New York (March 2, 2023) — The American Geriatrics Society (AGS) supports the decision from the Centers for Medicare and Medicaid Services (CMS) to not reconsider its prior national coverage determination (NCD) for Food and Drug Administration (FDA)-approved monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s disease (AD).  We appreciate CMS’ commitment to expeditiously review any new evidence that comes available that could lead to a reconsideration and change in the NCD, such as evidence that answers the Coverage with Evidence Development (CED) questions or approval by the FDA based upon evidence of clinical benefit.

• AGS partners with other US healthcare professional organizations to promote the importance of #vaccinations and early treatment of COVID-19 and influenza cases this fall and winter. Read the full press release: http://ow.ly/EA9W50LJZfx

Statement from: American Academy of Family Physicians, American Association of Nurse Practitioners, American Academy of Physician Associates, American College of Emergency Physicians, American College of Physicians, American College of Obstetricians and Gynecologists, American Geriatrics Society, American Medical Association, American Osteopathic Association, Council of Medical Specialty Societies, Infectious Diseases Society of America, and AMDA – The Society for Post-Acute and Long-Term Care Medicine

NEW YORK (November 21, 2022) – Given the anticipated increase in COVID-19 and influenza cases this fall and winter, America’s healthcare professional organizations are coming together to remind the public of the importance of vaccinations and early treatment. A strong recommendation from a trusted clinician is one of the most effective strategies to increase vaccine uptake. We encourage our members to use every interaction with patients as an opportunity to make strong vaccine recommendations, educate and answer questions about prevention and treatment options, encourage vaccination, and where feasible provide vaccination.

• The public comment period for reviewing the 2022 AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults is now open through December 9th! Click here for more details: http://ow.ly/2ZGZ50LAaZc

NEW YORK (November 10, 2022) —The American Geriatrics Society (AGS) today opened a public comment period for reviewing the draft updated 2022 AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. Last updated in 2019, the AGS Beers® Criteria remain one of the most frequently cited reference tools in geriatrics, detailing certain types of medications which may be inappropriate to prescribe to older people who are not receiving hospice or palliative care. Comments from any and all members of the public—accepted only at https://www.americangeriatrics.org/form/ags-beers-criteria-public-comment through 5pm ET on December 9, 2022—will help inform the final version of the AGS 2022 Updated Beers® Criteria, slated for release this fall. 

For their proposed 2022 update, the interprofessional panel of geriatrics experts responsible for the AGS Beers® Criteria identified more than 40 potentially problematic medications or classes of medications presently organized across five lists: